Brazil and Mexico are aligning drug rules through ANVISA and COFEPRIS. The move aims to speed access to medicines across Latin America.
← News
Public Health Systems Public Health Systems Health
Brazil and Mexico: The Benefits of Regulatory Convergence
Brazil And Mexico Countries involved
ANVISA And COFEPRIS Regulators
Faster Medicine Access Aim